With 6 rivals in the U.S., why would Lilly shell out up to $1B for Innovent's PD-1 med Tyvyt?
admin 21st August 2020 Uncategorised 0 With 6 rivals in the U.S., why would Lilly shell out up to $1B for Innovent’s PD-1 med Tyvyt?
aliu
Fri, 08/21/2020 – 09:53
More: With 6 rivals in the U.S., why would Lilly shell out up to B for Innovent's PD-1 med Tyvyt?
Source: fierce